CIK 0001756262 · Large accelerated filer
TransMedics Group, Inc.
Sign in to watch- Ticker
- TMDX
- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- FY end
- Dec 31
- Incorporated
- MA
- Entity type
- operating
- Phone
- 9785520900
- Business address
- 200 MINUTEMAN ROAD, ANDOVER, MA, 01810
- Open-market buys, last 90 days
- $109,058
- in 1 filing
- Open-market sales, last 90 days
- $385,464
- in 1 filing
Net −$276,406. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-04-04 | Khayal Tamer I Chief Commercial Officer | Option exercise 10b5-1 | +2,917 | $16.14 | $47K | 30,132 |
| 2024-04-04 | Khayal Tamer I Chief Commercial Officer | Sale 10b5-1 | −4,947 | $80.36 | $398K | 25,185 |
| 2024-04-04 | Khayal Tamer I Chief Commercial Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −2,030 | 24,917 | ||
| 2024-04-04 | Khayal Tamer I Chief Commercial Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −2,917 | 12,729 | ||
| 2024-04-03 | Khayal Tamer I Chief Commercial Officer | Option exercise 10b5-1 | +5,053 | $13.28 | $67K | 30,238 |
| 2024-04-03 | Khayal Tamer I Chief Commercial Officer | Sale 10b5-1 | −5,053 | $80.06 | $405K | 25,185 |
| 2024-04-03 | Khayal Tamer I Chief Commercial Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −5,053 | 26,947 | ||
| 2024-04-01 | Gordon Stephen Chief Financial Officer | Option exercise 10b5-1 | +15,000 | $38.46 | $577K | 38,299 |
| 2024-04-01 | Gordon Stephen Chief Financial Officer | Sale 10b5-1 | −15,000 | $74.01 | $1.1M | 23,299 |
| 2024-04-01 | Gordon Stephen Chief Financial Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −15,000 | 37,477 | ||
| 2024-03-08 | Khayal Tamer I Chief Commercial Officer | Option exercise 10b5-1 | +100 | $16.14 | $2K | 26,602 |
| 2024-03-08 | Khayal Tamer I Chief Commercial Officer | Sale 10b5-1 | −100 | $90.04 | $9K | 26,502 |
| 2024-03-08 | Khayal Tamer I Chief Commercial Officer | Sale 10b5-1 | −1,317 | $87.63 | $115K | 25,185 |
| 2024-03-08 | Khayal Tamer I Chief Commercial Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −100 | 15,646 | ||
| 2024-03-08 | Gordon Stephen Chief Financial Officer | Sale | −1,903 | $87.63 | $167K | 23,299 |
| 2024-03-04 | Gordon Stephen Chief Financial Officer | Option exercise 10b5-1 | +15,000 | $38.46 | $577K | 40,202 |
| 2024-03-04 | Gordon Stephen Chief Financial Officer | Sale 10b5-1 | −15,000 | $82.80 | $1.2M | 25,202 |
| 2024-03-04 | Gordon Stephen Chief Financial Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −15,000 | 52,477 | ||
| 2024-03-01 | Khayal Tamer I Chief Commercial Officer | Option exercise 10b5-1 | +10,000 | $13.28 | $133K | 36,502 |
| 2024-03-01 | Khayal Tamer I Chief Commercial Officer | Sale 10b5-1 | −2,868 | $81.49 | $234K | 33,634 |
Page 19 of 20 · 390 trades